ALPS ETF TR - MED BREAKTHGH (SBIO)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / MED BREAKTHGH
Total 13F shares
1,295,478
Share change
-49,408
Total reported value
$42,712,132
Put/Call ratio
53%
Price per share
$32.94
Number of holders
34
Value change
-$1,463,633
Number of buys
10
Number of sells
20

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q4 2023

As of 31 Dec 2023 ALPS ETF TR - MED BREAKTHGH (SBIO) had 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 1,295,478 shares of stock of the company.
Largest 10 holders included DAVENPORT & Co LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, UBS Group AG, NTV ASSET MANAGEMENT LLC, Strategic Financial Services, Inc,, LPL Financial LLC, CITADEL ADVISORS LLC, and GTS SECURITIES LLC.
This table shows 34 institutional shareholders of the security as of 31 Dec 2023.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.